Literature DB >> 33535989

Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection.

Ya Yang1, Xiaogang Hu2, Lirong Xiong1, Peishu Fu1, Wei Feng1, Wei Li1, Liwen Zhang3, Fengjun Sun4.   

Abstract

BACKGROUND: The impact of COVID-19 has been devastating on a global scale. The negative conversion time (NCT) of SARS-CoV-2 RNA is closely related to clinical manifestation and disease progression in COVID-19 patients. Our study aimed to predict factors associated with prolonged NCT of SARS-CoV-2 RNA in mild/moderate COVID-19 patients.
METHODS: The clinical features, laboratory data and treatment outcomes of COVID-19 patients were retrospectively analyzed. Then univariate and multivariate analysis were used to screen out risk factors of influencing prolonged NCT of SARS-CoV-2 RNA.
RESULTS: Thirty-two hospitalized mild/moderate COVID-19 patients were enrolled. The general clinical symptoms were cough (78.1%), fever (75%), diarrhea (68.8%), expectoration (56.3%), and nausea (37.5%). More than 40% of the patients had decreased erythrocyte, hemoglobin and leucocyte and 93.8% patients were detected in abnormalities of chest CT. The median NCT of SARS-CoV-2 RNA was 19.5 days (IQR: 14.25-25). Univariate analysis found fever, nausea, diarrhea and abnormalities in chest CTs were positively associated with prolonged NCT of viral RNA (P< 0.05). The multivariate Cox proportional hazard model revealed that fever [Exp (B), 0.284; 95% CI, 0.114-0.707; P<0.05] and nausea [Exp (B), 0.257; 95%CI, 0.096-0.689; P<0.05] were two significant independent factors.
CONCLUSIONS: Fever and nausea were two significant independent factors in prolonged NCT of viral RNA in mild/moderate COVID-19 patients, which provided a useful references for disease progression and treatment of COVID-19.

Entities:  

Keywords:  COVID-19; Clinical characteristics; Negative conversion time; SARS-CoV-2

Year:  2021        PMID: 33535989     DOI: 10.1186/s12879-021-05851-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  1 in total

1.  The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries.

Authors:  Tijana Kovacevic; Branislava Miljkovic; Momir Mikov; Svjetlana Stojisavljevic Satara; Sasa Dragic; Danica Momcicevic; Pedja Kovacevic
Journal:  Dose Response       Date:  2019-05-20       Impact factor: 2.658

  1 in total
  2 in total

1.  Dynamic changes of IgM and IgG antibodies in asymptomatic patients as an effective way to detect SARS-CoV-2 infection.

Authors:  Ping Li; Ge Shen; Zhenhua Zhu; Shengjie Shi; Yan Hu; Ziyan Zeng; Hui Zhou; Qiong Li; Pan Zhu; Gang Yang; Zugui Liu; Huiyuan Fu; Junyu Hu; Ying He; Qingting Yang; Miao Dai; Dan Zhou; Qingqing Lu; Xiaobing Xie
Journal:  J Clin Lab Anal       Date:  2021-12-16       Impact factor: 2.352

2.  Clinical Characteristics and Treatment Outcomes of Mild to Moderate COVID-19 Patients at Tertiary Care Hospital, Al Baha, Saudi Arabia: A Single Centre Study.

Authors:  Mohammad Albanghali; Saleh Alghamdi; Mohammed Alzahrani; Bassant Barakat; Abdul Haseeb; Jonaid Ahmad Malik; Sakeel Ahmed; Sirajudheen Anwar
Journal:  J Infect Public Health       Date:  2022-02-03       Impact factor: 3.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.